CENTROSE LLC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KEYBIOSCIENCE AG, JIANGYIN USUN PHARMACEUTICAL CO LTD and RHYTHM METABOLIC INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Japan | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Prudent James R | 9 |
#2 | Thorson Jon S | 3 |
#3 | Charles R Hutchinson | 2 |
#4 | Jon S Thorson | 2 |
#5 | Jill Hutchinson Bollettieri | 2 |
#6 | Bollettieri Jill Hutchinson | 2 |
#7 | Hutchinson Charles B | 2 |
#8 | James R Prudent | 2 |
#9 | Hutchinson Charles R | 1 |
Publication | Filing date | Title |
---|---|---|
US2017049908A1 | Extracellular targeted drug conjugates | |
EP3328393A1 | Extracellular drug conjugates targeting cd20 | |
EP3104882A1 | Extracellular targeted drug conjugates | |
AU2010292172A1 | Extracellular targeted drug conjugates |